Patrick D Spangler sold $194k of OPRX
director at OptimizeRx Corp. 11,120 shares at an average of $17.49, traded Aug 28, 2025, filed Sep 11, 2025.
Score components
- +15RoleDirector
- +12Trade size$194k at market
- +5Share of holdings soldSold 20% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.0%, 3m -25.5%, 6m -68.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001296525-25-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 28, 2025 | SOpen-market sale Common Stock | -11,120 | $17.49 | $194k | 44,215 | Sep 11, 2025 |
Related signals
Other insiders at OptimizeRx Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 7Weak | OPRXsell OptimizeRx Corp | Edward Stelmakh Chief Finance & Strat Officer | $19k 1,388 shares | -1% | |
| 15Weak | OPRXsell OptimizeRx Corp | Stephen L Silvestro Chief Executive Officer | $30k 1,620 shares | -1% | |
| 35Weak | OPRXbuy OptimizeRx Corp | William J Febbo CEO | $100k 20,000 shares | +3% | |
| 12Weak | OptimizeRx Corp | Marion Odence-Ford General Counsel and CCO | $61k 4,000 shares | -26% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.